Novo Nordisk

Ozempic
Health

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

By
August 18, 2025
Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’
C-Suite

Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’

By
July 29, 2025
Novo Nordisk overtakes SAP as Europe’s most valuable company
Health

Novo Nordisk overtakes SAP as Europe’s most valuable company

By Lisa Pham and Bloomberg
June 13, 2025
A group of young women sit around a table at a restaurant.
Health

The Ozempic boom could be bad news for restaurants as more than half of GLP-1 users report cutting back on dining out, report finds

By
June 4, 2025
Ozempic CEO’s exit from Novo started with Teams call surprise
Finance

Ozempic CEO’s exit from Novo started with Teams call surprise

By Naomi Kresge and Bloomberg
May 16, 2025
Novo ousts CEO Jorgensen after Lilly competition hits shares
Tech

Novo ousts CEO Jorgensen after Lilly competition hits shares

By Eric Pfanner and Bloomberg
May 16, 2025
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
Health

Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study

By Jonel Aleccia and The Associated Press
May 12, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
Health

Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars

By
May 9, 2025
CVS strikes a deal to offer Wegovy at a discount
Health

CVS strikes a deal to offer Wegovy at a discount

By
May 1, 2025
Novo Nordisk slides on pressure from Lilly’s pill study
Retail

Novo Nordisk slides on pressure from Lilly’s pill study

By Marthe Fourcade and Bloomberg
April 22, 2025
LArs Freurgaard Jorgensen and Ursula von der Leyen pictured among Danish business leaders in 2024.
Health

Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs

By
April 9, 2025
Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?
Magazine

Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?

By
March 31, 2025
SAP topples Novo to become Europe’s most-valuable listed company
Finance

SAP topples Novo to become Europe’s most-valuable listed company

By Henry Ren and Bloomberg
March 24, 2025
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
Retail

Roche, Zealand Pharma in $5.3 billion pact for obesity drugs

By Paula Doenecke, Naomi Kresge and Bloomberg
March 12, 2025
Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher
Finance

Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher

By
March 7, 2025

Most Popular